205 related articles for article (PubMed ID: 36977968)
1. The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients.
Mustonen J; Rautiainen P; Lamidi ML; Lavikainen P; Martikainen J; Laatikainen T
Acta Diabetol; 2023 Jul; 60(7):891-898. PubMed ID: 36977968
[TBL] [Abstract][Full Text] [Related]
2. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.
Choudhary P; Kolassa R; Keuthage W; Kroeger J; Thivolet C; Evans M; Ré R; de Portu S; Vorrink L; Shin J; Habteab A; Castañeda J; da Silva J; Cohen O;
Lancet Diabetes Endocrinol; 2022 Oct; 10(10):720-731. PubMed ID: 36058207
[TBL] [Abstract][Full Text] [Related]
3. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
[No Abstract] [Full Text] [Related]
4. Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia.
Davis TME; Dwyer P; England M; Fegan PG; Davis WA
Diabetes Technol Ther; 2020 May; 22(5):367-373. PubMed ID: 31724878
[No Abstract] [Full Text] [Related]
5. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
[TBL] [Abstract][Full Text] [Related]
6. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.
Charleer S; De Block C; Van Huffel L; Broos B; Fieuws S; Nobels F; Mathieu C; Gillard P
Diabetes Care; 2020 Feb; 43(2):389-397. PubMed ID: 31843948
[TBL] [Abstract][Full Text] [Related]
7. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D).
Brown RE; Chu L; Norman GJ; Abitbol A
Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977
[TBL] [Abstract][Full Text] [Related]
8. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
[TBL] [Abstract][Full Text] [Related]
9. Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia.
Charleer S; De Block C; Bolsens N; Van Huffel L; Nobels F; Mathieu C; Gillard P
Diabetes Technol Ther; 2023 Apr; 25(4):231-241. PubMed ID: 36648249
[No Abstract] [Full Text] [Related]
10. Recovery of hypoglycemic confidence using intermittently scanned continuous glucose monitoring among adults with type 1 diabetes with level 3 hypoglycemia: A prospective, single-center, single-arm study.
Takaike H; Miura J; Hoshina S; Takagi S; Takita M; Mochizuki S; Babazono T
Diabetes Res Clin Pract; 2023 Oct; 204():110890. PubMed ID: 37714304
[TBL] [Abstract][Full Text] [Related]
11. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
[TBL] [Abstract][Full Text] [Related]
12. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
[TBL] [Abstract][Full Text] [Related]
13. Personalizing the Use of a Intermittently Scanned Continuous Glucose Monitoring Device in Individuals With Type 1 Diabetes: A Cost-Effectiveness Perspective in the Netherlands (FLARE-NL 9).
Emamipour S; van Dijk PR; Bilo HJG; Edens MA; van der Galiën O; Postma MJ; Feenstra TL; van Boven JFM
J Diabetes Sci Technol; 2024 Jan; 18(1):135-142. PubMed ID: 35815617
[TBL] [Abstract][Full Text] [Related]
14. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial.
Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J
Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050
[TBL] [Abstract][Full Text] [Related]
15. To evaluate the use and clinical effect of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: Results of a multicentre study.
Moreno-Fernandez J; Sastre J; Pinés P; Calderon-Vicente D; Gargallo J; Muñoz-Rodriguez JR
Endocrinol Diabetes Nutr (Engl Ed); 2023 Apr; 70(4):270-276. PubMed ID: 37116972
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
Ajjan RA; Heller SR; Everett CC; Vargas-Palacios A; Higham R; Sharples L; Gorog DA; Rogers A; Reynolds C; Fernandez C; Rodrigues P; Sathyapalan T; Storey RF; Stocken DD
Diabetes Care; 2023 Feb; 46(2):441-449. PubMed ID: 36516054
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.
Seidu S; Kunutsor SK; Ajjan RA; Choudhary P
Diabetes Care; 2024 Jan; 47(1):169-179. PubMed ID: 38117991
[TBL] [Abstract][Full Text] [Related]
18. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
Lancet Diabetes Endocrinol; 2023 Feb; 11(2):96-108. PubMed ID: 36702566
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
20. Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
Al Hayek AA; Al Dawish MA
Adv Ther; 2023 Jun; 40(6):2855-2868. PubMed ID: 37133646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
